Dr. Nirmish R. Shah

As director of Duke’s sickle cell transition program, my practice and research focuses on treating children and adults with sickle cell disease. When I work with children, I try to focus on teaching them about their condition and how to transition successfully to living with the disease as an adult. For all patients, I focus on providing the medical, social and psychological support they need to remain healthy. My research aims to increase engagement of sickle cell patients with their own care using mobile technology. Through the use of applications, we’re hoping to help patients, specifically children, better manage their symptoms and medications. Outside of work, I have a strong interest in art. In fact, one of my undergraduate majors was biological illustration. I enjoy drawing plants, animals and people. I’ve recently started getting back into this hobby.

Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Tetanus. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 125 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Tetanus.